![](/img/cover-not-exists.png)
A Phase II study of carboplatin and docetaxel followed by epstein-barr virus specific cytotoxic T Lymphocytes for refractory/relapsed EBV-positive nasopharyngeal carcinoma
Louis, C.U., Ramos, C., Kalra, M., Glisson, B., Liu, H., Herzog, C., Gee, A., Heslop, H.E., Brenner, M.K., Rooney, C., Gottschalk, S.Volume:
15
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2013.01.030
Date:
April, 2013
File:
PDF, 58 KB
english, 2013